Abstract
Oral contraceptives containing high doses of estrogen and progesterone have been associated with several harmful side effects. In contrast, the new low dose contraceptives, although effective, do not present the same risks; in fact their use seems beneficial in certain conditions. The female population was frightened during the 1970s: several patients stopped taking the pill following publication of articles in the non-medical press about the dangers of using the pill. The family physician must reassure the patient. The new low dose oral contraceptives are safe and effective.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Kay C. R. Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study. Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):762–765. doi: 10.1016/s0002-9378(16)32485-1. [DOI] [PubMed] [Google Scholar]
- Maheux R., Jenicek M., Cleroux R., Beauregard H., De Muylder X., Gratton N. M., Van Campenhout J. Oral contraceptives and prolactinomas: a case-control study. Am J Obstet Gynecol. 1982 May 15;143(2):134–138. doi: 10.1016/0002-9378(82)90641-x. [DOI] [PubMed] [Google Scholar]
- Spellacy W. N. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives. Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):732–734. doi: 10.1016/s0002-9378(16)32479-6. [DOI] [PubMed] [Google Scholar]